Your search returned 10 results.

Results
	1.	Use of trastuzumab in the treatment of metastatic endometrial cancer. [electronic resource] by Jewell, E Secord, A A Brotherton, T Berchuck, A Producer: 20070227 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery. [electronic resource] by Soper, J T Havrilesky, L J Secord, A A Berchuck, A Clarke-Pearson, D L Producer: 20050729 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity. [electronic resource] by Soper, J T Secord, A A Havrilesky, L J Berchuck, A Clarke-Pearson, D L Producer: 20070302 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Desmoplastic small round cell tumor masquerading as advanced ovarian cancer. [electronic resource] by Bland, A E Shah, A A Piscitelli, J T Bentley, R C Secord, A A Producer: 20081118 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers. [electronic resource] by Sinnathamby, G Zerfass, J Hafner, J Block, P Nickens, Z Hobeika, A Secord, A A Lyerly, H K Morse, M A Philip, R Producer: 20110418 In: Clinical and experimental immunology vol. 163 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin. [electronic resource] by Hahn, C A Jones, E L Blivin, J L Sanders, L L Yu, D Dewhirst, M W Secord, A A Prosnitz, L R Producer: 20051108 In: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma. [electronic resource] by Duska, L R Petroni, G R Varhegyi, N Brown, J Jelovac, D Moore, K N McGuire, W P Darus, C Barroilhet, L M Secord, A A Producer: 20210113 In: Gynecologic oncology vol. 157 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study. [electronic resource] by Phippen, N T Secord, A A Wolf, S Samsa, G Davidson, B Abernethy, A P Cella, D Havrilesky, L J Burger, R A Monk, B J Leath, C A Producer: 20170926 In: Gynecologic oncology vol. 147 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. [electronic resource] by Wright, J D Secord, A A Numnum, T M Rocconi, R P Powell, M A Berchuck, A Alvarez, R D Gibb, R K Trinkaus, K Rader, J S Mutch, D G Producer: 20080718 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD). [electronic resource] by Kushnir, C L Angarita, A M Havrilesky, L J Thompson, S Spahlinger, D Sinno, A K Tanner, E J Secord, A A Roche, K L Stone, R L Fader, A N Producer: 20150901 In: Gynecologic oncology vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)